Subject
Nature Reviews Cancer is a monthly review journal covering the field of oncology. It was established in 2001. The editor-in-chief is Anna Dart. Source: Wikipedia (en)
Editions published in Nature Reviews Cancer 200
Too many entities requested (2400). Only 200 are displayed.
-
A panoply of errors: polymerase proofreading domain mutations in cancer
-
The multifaceted roles of fatty acid synthesis in cancer
-
Deciphering the divergent roles of progestogens in breast cancer
-
The disparate origins of ovarian cancers: pathogenesis and prevention strategies.
-
Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer
-
Precision medicine for cancer with next-generation functional diagnostics
-
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
-
Sympathetic nervous system regulation of the tumour microenvironment
-
A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor
-
Hijacked in cancer: the KMT2 (MLL) family of methyltransferases
-
Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma
-
MicroRNA biogenesis pathways in cancer
-
Radioimmunotherapy of human tumours
-
DNA damage and the balance between survival and death in cancer biology
-
Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?
-
Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond
-
FAK in cancer: mechanistic findings and clinical applications
-
Mechanisms of disseminated cancer cell dormancy: an awakening field
-
IGF binding proteins in cancer: mechanistic and clinical insights
-
Hypermutation in human cancer genomes: footprints and mechanisms
-
The ID proteins: master regulators of cancer stem cells and tumour aggressiveness
-
PAK signalling during the development and progression of cancer
-
How ageing processes influence cancer
-
Serine, glycine and one-carbon units: cancer metabolism in full circle
-
Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma
-
Role of ABL family kinases in cancer: from leukaemia to solid tumours
-
Life history trade-offs in cancer evolution
-
WNT signalling pathways as therapeutic targets in cancer
-
Cancer drug resistance: an evolving paradigm
-
The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention
-
Retroviral oncogenes: a historical primer
-
Cancer imaging by optical coherence tomography: preclinical progress and clinical potential
Subject - wd:Q641657